CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice

Journal of Lipid Research

Volumn 44, Issue 12, 2003, Pages 2270-2277

  Goudriaan, Jeltje R ^a   Dahlmans, Vivian E H ^a   Teusink, Bas ^a   Ouwens, D Margriet ^c   Febbraio, Maria ^b   Maassen, J Anton ^c   Romijn, Johannes A ^c   Havekes, Louis M ^a,c   Voshol, Peter J ^a,c  

^a TNO   (Netherlands)

^b Department of Obstetrics Gynecology   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fatty acid transport; Glucose metabolism; Hepatic steatosis; Hyperinsulinemic clamp

Indexed keywords

CD36 ANTIGEN; FATTY ACID; GLUCOSE; INSULIN; PROTEIN KINASE B; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEFICIENCY; FATTY ACID BLOOD LEVEL; FATTY ACID TRANSPORT; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER; MALE; MOUSE; MUSCLE; NONHUMAN; PRIORITY JOURNAL; SPONTANEOUSLY HYPERTENSIVE RAT; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING; WILD TYPE;

ANIMALS; ANTIGENS, CD36; BLOOD GLUCOSE; BODY WEIGHT; EATING; GENE DELETION; INSULIN; INSULIN RESISTANCE; LIPIDS; LIVER; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; RATS; SIGNAL TRANSDUCTION; TRIGLYCERIDES; TRITIUM;

EID: 0346492572     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300143-JLR200     Document Type: Article

References (47)

1. Lewis, G. F., A. Carpentier, K. Adeli, and A. Giacca. 2002. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr. Rev. 23: 201-229.
2. Abumrad, N. A., M. R. el-Maghrabi, E. Z. Amri, E. Lopez, and P. A. Grimaldi. 1993. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J. Biol. Chem. 268:17665-17668.
3. Endemann, G., L. W. Stanton, K. S. Madden, C. M. Bryant, R. T. White, and A. A. Protter. 1993. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268: 11811-11816.
4. Greenwalt, D. E., R. H. Lipsky, C. F. Ockenhouse, H. Ikeda, N. N. Tandon, and G. A. Jamieson. 1992. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood. 80: 1105-1115.
5. Silverstein, R. L., A. S. Asch, and R. L. Nachman. 1989. Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J. Clin. Invest. 84: 546-552.
6. Tandon, N. N., U. Kralisz, and G. A. Jamieson. 1989. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J. Biol. Chem. 264: 7576-7583.
7. Abumrad, N., C. Harmon, and A. Ibrahimi. 1998. Membrane transport of long-chain fatty acids: evidence for a facilitated process. J. Lipid Res. 39: 2309-2318.
8. Van Nieuwenhoven, F. A., C. P. Verstijnen, N. A. Abumrad, P. H. Willemsen, G. J. Van Eys, G. J. Van der Vusse, and J. F. Glatz. 1995. Putative membrane fatty acid translocase and cytoplasmic fatty acid-binding protein are co-expressed in rat heart and skeletal muscles. Biochem. Biophys. Res. Commun. 207: 747-752.
9. Coburn, C. T., F. F. J. Knapp, M. Febbraio, A. L. Beets, R. L. Silverstein, and N. A. Abumrad. 2000. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J. Biol. Chem. 275: 32523-32529.
10. Febbraio, M., N. A. Abumrad, D. P. Hajjar, K. Sharma, W. Cheng, S. F. Pearce, and R. L. Silverstein. 1999. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J. Biol. Chem. 274: 19055-19062.
11. Aitman, T. J., A. M. Glazier, C. A. Wallace, L. D. Cooper, P. J. Norsworthy, F. N. Wahid, K. M. Al-Majali, P. M. Trembling, C. J. Mann, C. C. Shoulders, D. Graf, E. St Lezin, T. W. Kurtz, V. Kren, M. Pravenec, A. Ibrahimi, N. A. Abumrad, L. W. Stanton, and J. Scott. 1999. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat. Genet. 21: 76-83.
12. Pravenec, M., V. Landa, V. Zidek, A. Musilova, V. Kren, L. Kazdova, T. J. Aitman, A. M. Glazier, A. Ibrahimi, N. A. Abumrad, N. Qi, J. M. Wang, E. M. St Lezin, and T. W. Kurtz. 2001. Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat. Genet. 27:156-158.
13. Ibrahimi, A., A. Bonen, W. D. Blinn, T. Hajri, X. Li, K. Zhong, R. Cameron, and N. A. Abumrad. 1999. Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J. Biol. Chem. 274: 26761-26766.
14. Hajri, T., X. X. Han, A. Bonen, and N. A. Abumrad. 2002. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J. Clin. Invest. 109: 1381-1389.
15. Zambon, A., S. I. Hashimoto, and J. D. Brunzell. 1993. Analysis of techniques to obtain plasma for measurement of levels of free fatty acids. J. Lipid Res. 34: 1021-1028.
16. Koopmans, S. J., S. F. de Boer, H. C. Sips, J. K. Radder, M. Frolich, and H. M. Krans. 1991. Whole body and hepatic insulin action in normal, starved, and diabetic rats. Am. J. Physiol. 260: E825-E832.
17. Havekes, L. M., E. C. de Wit, and H. M. Princen. 1987. Cellular free cholesterol in Hep G2 cells is only partially available for down-regulation of low-density-lipoprotein receptor activity. Biochem. J. 247:739-746.
18. Post, S. M., E. C. de Wit, and H. M. Princen. 1997. Cafestol, the cholesterol-raising factor in boiled coffee, suppresses bile acid synthesis by downregulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase in rat hepatocytes. Arterioscler. Thromb. Vasc. Biol. 17: 3064-3070.
19. Rossetti, L., D. L. Rothman, R. A. DeFronzo, and G. I. Shulman. 1989. Effect of dietary protein on in vivo insulin action and liver glycogen repletion. Am. J. Physiol. 257: E212-E219.
20. Rossetti, L., and A. Giaccari. 1990. Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats. J. Clin. Invest. 85: 1785-1792.
21. Kraegen, E. W., D. E. James, A. B. Jenkins, and D. J. Chisholm. 1985. Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. Am. J. Physiol. 248: E353-E362.
22. Previs, S. F., D. J. Withers, J. M. Ren, M. F. White, and G. I. Shulman. 2000. Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J. Biol. Chem. 275: 38990-38994.
23. Rensen, P. C., N. Herijgers, M. H. Netscher, S. C. Meskers, M. van Eck, and T. J. van Berkel. 1997. Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo. J. Lipid Res. 38: 1070-1084.
24. Lavoinne, A., A. Baquet, and L. Hue. 1987. Stimulation of glycogen synthesis and lipogenesis by glutamine in isolated rat hepatocytes. Biochem. J. 248: 429-437.
25. Dufresne, S. D., C. Bjorbaek, K. El-Haschimi, Y. Zhao, W. G. Aschenbach, D. E. Moller, and L. J. Goodyear. 2001. Altered extracellular signal-regulated kinase signaling and glycogen metabolism in skeletal muscle from p90 ribosomal S6 kinase 2 knockout mice. Mol. Cell. Biol. 21: 81-87.
26. Ouwens, D. M., G. C. van der Zon, G. J. Pronk, J. L. Bos, W. Moller, B. Cheatham, C. R. Kahn, and J. A. Maassen. 1994. A mutant insulin receptor induces formation of a Shc-growth factor receptor bound protein 2 (Grb2) complex and p21ras-GTP without detectable interaction of insulin receptor substrate 1 (IRS1) with Grb2. Evidence for IRS1-independent p21ras-GTP formation. J. Biol. Chem. 269: 33116-33122.
27. Voshol, P. J., M. C. Jong, V. E. Dahlmans, D. Kratky, S. Levak-Frank, R. Zechner, J. A. Romijn, and L. M. Havekes. 2001. In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake. Diabetes. 50: 2585-2590.
28. Shulman, G. I. 2000. Cellular mechanisms of insulin resistance. J. Clin. Invest. 106: 171-176.
29. Koopmans, S. J., M. C. Jong, I. Que, V. E. Dahlmans, H. Pijl, J. K. Radder, M. Frolich, and L. M. Havekes. 2001. Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1. Diabetologia. 44: 437-443.
30. Kim, J. K., O. Gavrilova, Y. Chen, M. L. Reitman, and G. I. Shulman. 2000. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J. Biol. Chem. 275: 8456-8460.
31. Pan, D. A., S. Lillioja, A. D. Kriketos, M. R. Milner, L. A. Baur, C. Bogardus, A. B. Jenkins, and L. H. Storlien. 1997. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes. 46: 983-988.
32. Perseghin, G., P. Scifo, F. De Cobelli, E. Pagliato, A. Battezzati, C. Arcelloni, A. Vanzulli, G. Testolin, G. Pozza, A. Del Maschio, and L. Luzi. 1999. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes. 48: 1600-1606.
33. Frykman, P. K., M. S. Brown, T. Yamamoto, J. L. Goldstein, and J. Herz. 1995. Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA. 92: 8453-8457.
34. Goudriaan, J. R., P. J. Tacken, V. E. Dahlmans, M. J. Gijbels, K. W. van Dijk, L. M. Havekes, and M. C. Jong. 2001. Protection from obesity in mice lacking the VLDL receptor. Arterioscler. Thromb. Vasc. Biol. 21: 1488-1493.
35. Jong, M. C., K. W. van Dijk, V. E. Dahlmans, B. H. Van der Boom, K. Kobayashi, K. Oka, G. Siest, L. Chan, M. H. Hofker, and L. M. Havekes. 1999. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor. Biochem. J. 338: 281-287.
36. Jong, M. C., P. J. Voshol, M. Muurling, V. E. Dahlmans, J. A. Romijn, H. Pijl, and L. M. Havekes. 2001. Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1. Diabetes. 50: 2779-2785.
37. Weinstock, P. H., S. Levak-Frank, L. C. Hudgins, H. Radner, J. M. Friedman, R. Zechner, and J. L. Breslow. 1997. Lipoprotein lipase controls fatty acid entry into adipose tissue, but fat mass is preserved by endogenous synthesis in mice deficient in adipose tissue lipoprotein lipase. Proc. Natl. Acad. Sci. USA. 94: 10261-10266.
38. Barzilai, N., S. Banerjee, M. Hawkins, W. Chen, and L. Rossetti. 1998. Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. J. Clin. Invest. 101: 1363-1361.
39. Codina, J., M. Vall, and E. Herrera. 1980. Changes in plasma glucose, insulin and glucagon levels, glucose tolerance tests and insulin sensitivity with age in the rat. Diabete Metab. 6: 135-139.
40. Gupta, G., J. A. Cases, L. She, X. H. Ma, X. M. Yang, M. Hu, J. Wu, L. Rossetti, and N. Barzilai. 2000. Ability of insulin to modulate hepatic glucose production in aging rats is impaired by fat accumulation. Am. J. Physiol. Endocrinol. Metab. 278: E985-E991.
41. Muurling, M., M. C. Jong, R. P. Mensink, G. Hornstra, V. E. Dahlmans, H. Pijl, P. J. Voshol, and L. M. Havekes. 2002. A low-fat diet has a higher potential than energy restriction to improve high-fat diet-induced insulin resistance in mice. Metabolism. 51: 695-701.
42. Gotoda, T., Y. Iizuka, N. Kato, J. Osuga, M. T. Bihoreau, T. Murakami, Y. Yamori, H. Shimano, S. Ishibashi, and N. Yamada. 1999. Absence of Cd36 mutation in the original spontaneously hypertensive rats with insulin resistance. Nat. Genet. 22: 226-228.
43. Stremmel, W., G. Strohmeyer, F. Borchard, S. Kochwa, and P. D. Berk. 1985. Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc. Natl. Acad. Sci. USA. 82: 4-8.
44. Kim, J. K., J. J. Fillmore, Y. Chen, C. Yu, I. K. Moore, M. Pypaert, E. P. Lutz, Y. Kako, W. Velez-Carrasco, I. J. Goldberg, J. L. Breslow, and G. I. Shulman. 2001. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc. Natl. Acad. Sci. USA. 98: 7522-7527.
45. Seppala-Lindroos, A., S. Vehkavaara, A. M. Hakkinen, T. Goto, J. Westerbacka, A. Sovijarvi, J. Halavaara, and H. Yki-Jarvinen. 2002. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J. Clin. Endocrinol. Metab. 87: 3023-3028.
46. Tiikkainen, M., M. Tamminen, A. M. Hakkinen, R. Bergholm, S. Vehkavaara, J. Halavaara, K. Teramo, A. Rissanen, and H. Yki-Jarvinen. 2002. Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes. Obes. Res. 10: 859-867.
47. Saltiel, A. R., and C. R. Kahn. 2001. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 414: 799-806.